← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2013Last known activity
Dec 31, 2019
Defunct as of Dec 31, 2020
Timeline
2000s
- Jun 1, 2007
Adynxx, Inc.— Founded
2010s
- Oct 15, 2018
Alliqua BioMedical— Acquired
2020s
- Dec 31, 2020
Adynxx, Inc.— Defunct
Drugs by trial phase (3 distinct, 9 trials)
Other trials (0 own, 1 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (8)
- NCT04104919Lead sponsorPhase 2Dec 31, 2019
- NCT03797612Lead sponsorPhase 2May 1, 2019
- NCT02807428Study directorPhase 2Feb 20, 2017
- NCT02807428Lead sponsorPhase 2Feb 20, 2017
- NCT02081703Study directorPhase 2May 1, 2014
- NCT02081703Lead sponsorPhase 2May 1, 2014
- NCT01731730Study directorPhase 2Jan 1, 2013
- NCT01731730Lead sponsorPhase 2Jan 1, 2013
Details
- Founded
- San Francisco, CA, US Jun 1, 2007
- Last known activity
- Dec 31, 2019